Phases AI

AI-powered clinical trial recruitment

San Francisco, CA, US

Phases AI develops AI-powered patient recruitment solutions to automate clinical trials. Their platform targets clinical research organizations.

Shareable draft

Check out Phases AI on @MedStartr Today Phases AI develops AI-powered patient recruitment solutions to automate clinical trials. Their platform targets clinical research organizations. https://www.linkedin.com/company/phases-ai #DrugDiscoveryDevelopment #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/CwQIvTvXcSM

Get Involved in Phases AI

How We Help

Problem Statement

Drug development is costly, time-consuming, and often fails due to inefficient clinical trial recruitment, with 80% of studies missing targets, leading to significant financial losses for pharma companies and delayed cures.

Core Technology

AI agents for patient recruitment in clinical trials.

Key Differentiators

AI-powered patient recruitment solutions; Automation of clinical trials with AI agents

Clinical Focus

Clinical Trials; Patient Recruitment

Company Info

Business Model: B2B SaaS
Founded: 2025
Website: phases.ai

Technologies

Patient RecruitmentClinical Trials AutomationAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Live with customers; automating recruitment workflows at research sites and CROs. Converts 30+ minute screening conversations into 1-minute AI decisions. Pre-seed funded by Y Combinator S25.

🌐Website 💼LinkedIn

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Phases AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.